Infliximab no tratamento da sarcoidose - Experiência de um hospital central

Statistics

Série de casos

Infliximab for treating sarcoidosis patients, Portuguese experience

M. Aguiar

Corresponding author

m_aguiar@netcabo.pt

Autor para correspondência.

, N. Marçal, A.C. Mendes, A. Bugalho de Almeida

Serviço de Pneumologia 1, Hospital de Santa Maria, CHLN, EPE, Lisboa, Portugal

Read

17715

Times
was read the article

4516

Total PDF

13199

Total HTML

Share statistics

Article information

ISSN: 08732159
Original language: Portuguese

DOI:10.1016/S0873-2159(11)70020-4

The statistics are updated each day

Year/Month	Html	Pdf	Total

2025 6	33	11	44
2025 5	123	80	203
2025 4	111	65	176
2025 3	129	63	192
2025 2	89	75	164
2025 1	90	63	153
2024 12	83	53	136
2024 11	99	84	183
2024 10	77	111	188
2024 9	62	66	128
2024 8	91	75	166
2024 7	108	62	170
2024 6	106	48	154
2024 5	60	48	108
2024 4	44	37	81
2024 3	63	39	102
2024 2	51	24	75
2024 1	43	35	78
2023 12	39	41	80
2023 11	35	32	67
2023 10	40	49	89
2023 9	56	49	105
2023 8	39	30	69
2023 7	43	36	79
2023 6	48	45	93
2023 5	62	36	98
2023 4	44	52	96
2023 3	47	61	108
2023 2	43	45	88
2023 1	64	37	101
2022 12	49	38	87
2022 11	63	70	133
2022 10	53	37	90
2022 9	37	43	80
2022 8	47	49	96
2022 7	38	47	85
2022 6	33	35	68
2022 5	46	53	99
2022 4	42	34	76
2022 3	29	31	60
2022 2	45	35	80
2022 1	34	40	74
2021 12	41	47	88
2021 11	53	34	87
2021 10	56	48	104
2021 9	38	48	86
2021 8	37	37	74
2021 7	37	17	54
2021 6	44	38	82
2021 5	48	38	86
2021 4	129	110	239
2021 3	67	18	85
2021 2	55	26	81
2021 1	43	18	61
2020 12	20	8	28
2020 11	60	16	76
2020 10	28	25	53
2020 9	70	22	92
2020 8	62	29	91
2020 7	94	32	126
2020 6	82	15	97
2020 5	79	26	105
2020 4	67	30	97
2020 3	72	11	83
2020 2	71	31	102
2020 1	86	17	103
2019 12	70	30	100
2019 11	61	16	77
2019 10	82	18	100
2019 9	63	17	80
2019 8	72	18	90
2019 7	59	15	74
2019 6	59	11	70
2019 5	77	23	100
2019 4	66	38	104
2019 3	126	16	142
2019 2	124	20	144
2019 1	106	38	144
2018 12	80	18	98
2018 11	35	4	39
2018 10	40	9	49
2018 9	13	15	28
2018 8	23	38	61
2018 7	27	33	60
2018 6	31	34	65
2018 5	44	73	117
2018 4	42	72	114
2018 3	36	62	98
2018 2	29	25	54
2018 1	24	20	44
2017 12	40	17	57
2017 11	18	22	40
2017 10	30	21	51
2017 9	22	26	48
2017 8	19	24	43
2017 7	20	20	40
2017 6	35	30	65
2017 5	34	16	50
2017 4	18	12	30
2017 3	24	5	29
2017 2	16	17	33
2017 1	19	13	32
2016 12	22	8	30
2016 11	13	47	60
2016 10	7	14	21
2016 9	7	5	12
2016 8	2	8	10
2016 7	3	7	10
2016 6	0	12	12
2016 5	0	16	16
2016 4	51	2	53
2016 3	64	27	91
2016 2	74	32	106
2016 1	84	16	100
2015 12	51	21	72
2015 11	63	15	78
2015 10	73	20	93
2015 9	92	17	109
2015 8	96	18	114
2015 7	211	7	218
2015 6	104	5	109
2015 5	215	10	225
2015 4	198	18	216
2015 3	197	7	204
2015 2	223	20	243
2015 1	155	11	166
2014 12	146	18	164
2014 11	201	12	213
2014 10	264	17	281
2014 9	277	19	296
2014 8	250	15	265
2014 7	463	30	493
2014 6	208	16	224
2014 5	222	15	237
2014 4	190	13	203
2014 3	272	20	292
2014 2	216	20	236
2014 1	213	22	235
2013 12	187	12	199
2013 11	190	14	204
2013 10	231	10	241
2013 9	129	9	138
2013 8	137	12	149
2013 7	128	17	145
2013 6	127	12	139
2013 5	144	13	157
2013 4	145	19	164
2013 3	124	15	139
2013 2	122	24	146
2013 1	117	24	141
2012 12	83	12	95
2012 11	112	26	138
2012 10	110	18	128
2012 9	34	8	42
2012 1	491	0	491

Show all

Indexed in:

Follow us:

Statistics

Indexed in:

Follow us:

Statistics

Subscribe to our newsletter